These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Recurrent visual loss in a 64-year-old man. Murphy OC; Newsome SD Pract Neurol; 2020 Apr; 20(2):175-178. PubMed ID: 31649102 [No Abstract] [Full Text] [Related]
9. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review. Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis. Tajfirouz DA; Bhatti MT; Chen JJ Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369 [TBL] [Abstract][Full Text] [Related]
20. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. Zhong X; Chang Y; Tan S; Wang J; Sun X; Wu A; Peng L; Lau AY; Kermode AG; Qiu W BMC Neurol; 2019 May; 19(1):94. PubMed ID: 31072329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]